Cargando…

Pharmacogenetics – Challenges and Opportunities Ahead

Detalles Bibliográficos
Autor principal:	Zanger, Ulrich M.
Formato:	Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2010
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095373/ https://www.ncbi.nlm.nih.gov/pubmed/21607063 http://dx.doi.org/10.3389/fphar.2010.00112

Ejemplares similares

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
por: Zanger, Ulrich M., et al.
Publicado: (2013)

Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities
por: Zgheib, Nathalie K., et al.
Publicado: (2020)

Gastrointestinal Pharmacology: Challenges Ahead
por: Sanger, Gareth J
Publicado: (2010)

Analytical and Experimental Pharmacology, Challenges Ahead
por: Salomone, Salvatore
Publicado: (2010)

Systemic cancer therapy: achievements and challenges that lie ahead
por: Palumbo, Michael O., et al.
Publicado: (2013)

Pharmacogenetics in the Brazilian Population
por: Suarez-Kurtz, Guilherme
Publicado: (2010)

Pharmacogenetics in Primary Headache Disorders
por: Belyaeva, Irina I., et al.
Publicado: (2022)

Sirtuins and Disease: The Road Ahead
por: Carafa, Vincenzo, et al.
Publicado: (2012)

Patient Engagement in Kidney Research: Opportunities and Challenges Ahead
por: Molnar, Amber O., et al.
Publicado: (2017)

Relevance of G-quadruplex structures to pharmacogenetics
por: Cree, Simone L., et al.
Publicado: (2014)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
por: Agúndez, José A. G., et al.
Publicado: (2022)

Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions – Focus on Interactions with Cytochromes P450
por: Ryu, Chang S., et al.
Publicado: (2017)

Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions
por: Böhm, Ruwen, et al.
Publicado: (2016)

Actionable Pharmacogenetic Variation in the Slovenian Genomic Database
por: Hočevar, Keli, et al.
Publicado: (2019)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
por: Zhou, Lin, et al.
Publicado: (2022)

Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
por: Chua, E. W., et al.
Publicado: (2012)

Ensuring equity: Pharmacogenetic implementation in rural and tribal communities
por: Leitch, Tianna M., et al.
Publicado: (2022)

The Tara Oceans Project: New Opportunities and Greater Challenges Ahead
por: Zhang, Houjin, et al.
Publicado: (2015)

Future technologies and techniques in peritoneal dialysis—opportunities and challenges ahead
por: Holmes, Clifford J., et al.
Publicado: (2008)

Mental Healthcare Act 2017 – The way ahead: Opportunities and Challenges
por: Jagadish, A., et al.
Publicado: (2019)

Processing of Complex Materials in the Copper Industry: Challenges and Opportunities Ahead
por: Flores, Gerardo Alvear, et al.
Publicado: (2020)

The Upcoming Role for Nursing and Assistive Robotics: Opportunities and Challenges Ahead
por: Christoforou, Eftychios G., et al.
Publicado: (2020)

Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
por: Roco, Ángela, et al.
Publicado: (2014)

Therapeutic Drug Monitoring and Pharmacogenetic Testing in Northern China
por: Zhang, Chunyan, et al.
Publicado: (2021)

Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
por: Garcia-Agundez, Augusto, et al.
Publicado: (2022)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
por: Sessa, Francesco, et al.
Publicado: (2023)

Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2023)

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC(®)) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
por: Blazy, Christopher, et al.
Publicado: (2022)

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data
por: Zhou, Yitian, et al.
Publicado: (2018)

Whole Genome Amplification of DNA for Genotyping Pharmacogenetics Candidate Genes
por: Philips, Santosh, et al.
Publicado: (2012)

Pharmacogenetic aspects of addictive behaviors
por: Hejazi, Nadia S.
Publicado: (2007)

Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014)

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
por: Abdullah-Koolmees, Heshu, et al.
Publicado: (2021)

Targeting Autophagy to Treat Cancer: Challenges and Opportunities
por: Lim, Junghyun, et al.
Publicado: (2020)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

OX(1) and OX(2) orexin/hypocretin receptor pharmacogenetics
por: Thompson, Miles D., et al.
Publicado: (2014)

Pharmacogenetic Variation in Over 100 Genes in Patients Receiving Acenocumarol
por: Gonzalez-Covarrubias, Vanessa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_73p7jq8mvr26bb2kvvlmogvn0h